PMGC Holdings (ELAB) EBITDA (2022 - 2026)
PMGC Holdings' (ELAB) quarterly EBITDA came in at -$3.8 million in Q2 2026, down 14.82% quarter-over-quarter from -$3.3 million in Q1 2026.
Analysis
PMGC Holdings (ELAB) EBITDA (2022 - 2026) Analysis & Trends
PMGC Holdings has disclosed EBITDA across 5 years of filings, most recently posting -$3.8 million for Q2 2026.
- In Q2 2026, EBITDA changed N/A year-over-year to -$3.8 million; the TTM figure through Jun 2026 stood at -$11.9 million (changed N/A YoY), while the FY2025 annual figure was -$6.9 million, changed N/A from the prior year.
- EBITDA came in at -$3.8 million for Q2 2026 at PMGC Holdings, down from -$3.3 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $1.1 billion in Q4 2022 to a low of -$471.8 million in Q3 2022.
- Average EBITDA over 5 years is $48.0 million, with a median of -$1.4 million recorded in 2024.
- Year-over-year, EBITDA jumped 99.83% in 2023 and slumped 139.05% in 2025.
- Over 5 years, EBITDA stood at $1.1 billion in 2022, then tumbled by 100.1% to -$1.1 million in 2023, then climbed by 14.9% to -$919837.0 in 2024, then slumped by 173.05% to -$2.5 million in 2025, then sank by 52.38% to -$3.8 million in 2026.
- Per Business Quant data, the three most recent EBITDA figures were -$3.8 million in Q2 2026, -$3.3 million in Q1 2026, and -$2.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.09 Bn | 193.10 Bn | 7.24 Bn | 3.51 Bn |
| 2 | Gilead Sciences | 179.68 Bn | 176.50 Bn | 6.22 Bn | -10.39 Bn |
| 3 | Vertex Pharmaceuticals | 131.39 Bn | 123.54 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 81.79 Bn | 73.79 Bn | 3.93 Bn | 1.29 Bn |
| 5 | Argenx Se | 61.15 Bn | 55.97 Bn | 1.37 Bn | 493.00 Mn |
| 6 | Moderna | 53.35 Bn | 48.21 Bn | 52.00 Mn | -815.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.40 Bn | 30.10 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Biogen | 31.66 Bn | 30.38 Bn | 1.96 Bn | -644.50 Mn |
| 9 | Roivant Sciences | 29.14 Bn | 29.14 Bn | 1.16 Mn | -365.99 Mn |
| 10 | PMGC Holdings | 2.25 Mn | -16.55 Mn | 385,691.00 | -3.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.83 Mn |
| Mar 31, 2026 | -3.33 Mn |
| Dec 31, 2025 | -2.51 Mn |
| Sep 30, 2025 | -2.20 Mn |
| Sep 30, 2024 | -919,837.00 |
| Jun 30, 2024 | -1.41 Mn |
| Mar 31, 2024 | -1.68 Mn |
| Dec 31, 2023 | -1.08 Mn |
| Sep 30, 2023 | -785,551.00 |
| Jun 30, 2023 | -1.05 Mn |
| Mar 31, 2023 | -846,389.00 |
| Dec 31, 2022 | 1.12 Bn |
| Sep 30, 2022 | -471.84 Mn |